Serum Concentration of CD137 and Tumor Infiltration by M1 Macrophages Predict the Response to Sintilimab plus Bevacizumab Biosimilar in Advanced Hepatocellular Carcinoma PatientsWen Zhang, Aiping Zhou|Clinical Cancer Research|2022Cited by 56
CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trialJia Liu, Lin Shen, Aiping Zhou et al.|Nature Medicine|2025Cited by 29